International Cancer Advocacy Network (ICAN)

November 09, 2022

New treatments may stall lung cancer progression in patients with EGFR exon 20 insertion mutations.

October 20, 2022

A man with lung cancer shares how learning about his EGFR exon 20 insertion mutation soon after being diagnosed has allowed him to be aggressive when pursuing a cancer treatment tailored to his rare mutation.

May 27, 2022

Before closing out their discussion on treatment for EGFR Exon 20–Positive NSCLC, experts discuss prominent unmet needs in this setting.

May 20, 2022

A shared discussion on the importance of enrolling in clinical trials for EGFR exon 20–positive NSCLC and improving access to novel therapy for patients.

May 20, 2022

A focused conversation on how a patient can maintain and improve quality of life while receiving therapy for non–small cell lung cancer.

May 13, 2022

Comprehensive discussion on support for patients receiving therapy for NSCLC, ranging from care team members to education materials to support groups.